Audrey Laroche-Clary
Audrey Laroche-Clary is an expert in Oncology at Institut Bergonié (France). Audrey Laroche-Clary has authored 69 publications, the most recent in 2025, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 223 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2000 - 2025
Number : 69
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 Expression. PMID 40560936 — cells, neoplasms, sarcoma, cell line, therapeutics, apoptosis, tissues, cell cycle | Clin Cancer Res | 2025 | 0 |
| Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue Sarcomas. PMID 37982819 — sarcoma, prognosis, drug therapy, clustered regularly interspaced short palindromic repeats, protein kinases, therapeutics, neoplasms, protein serine-threonine kinases, genome, tissues, dna-activated protein kinase, chemotherapy | Clin Cancer Res | 2023 | 2 |
| Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications. PMID 37259134 — sarcoma, libraries, clustered regularly interspaced short palindromic repeats, therapeutics, genes, genome, tissues, synthetic lethal mutations | Exp Hematol Oncol | 2023 | 1 |
| Prognostic impact of circulating tumor cells in patients with soft-tissue sarcomas: a prospective study. PMID 36738132 — sarcoma, neoplasms, prospective studies, tissues, neoplastic cells, circulating | Cancer Commun (Lond) | 2023 | 7 |
| Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis. PMID 35452514 — hematologic diseases, brain, thrombosis, neutrophils, blood platelets, antigen-antibody complex, sars-cov-2 | Blood Adv | 2022 | 2 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study of a Selective T Cell Receptor (TCR) Targeting Bifunctional Antibody fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626 — urinary bladder, skin, urinary bladder neoplasms, cells, biliary tract neoplasms, merkel cells, lung, microsatellite repeats, vulvar neoplasms, stomach, docetaxel, carcinoma, squamous cell, uterine cervical neoplasms, melanoma, urogenital neoplasms, antineoplastic agents, genital neoplasms, female, neoplasms, carcinoma, non-small-cell lung, gastrointestinal neoplasms, solutions, immunotherapy, herpesvirus 4, human, immune checkpoint inhibitors, lung neoplasms, nasopharyngeal neoplasms, small cell lung carcinoma, viruses, neoplasms by site, biliary tract, head and neck neoplasms, epstein-barr virus infections, esophageal neoplasms, abdominal neoplasms, colorectal neoplasms, infusions, intravenous, t-lymphocytes, papillomavirus infections, carcinoma, basal cell, carcinoma, merkel cell, irinotecan, stomach neoplasms, infections, microsatellite instability, virus diseases, receptors, antigen, t-cell, vulvar diseases, endometrial neoplasms, msi-h, carcinoma, female, head, neck | Phase 1/Phase 2 | Recruiting | 2023 |
LeadR Networks
Main global connection map